Jump to content

Post hoc analysis: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

13 April 2024

15 March 2024

17 February 2024

25 January 2024

26 November 2023

13 August 2023

14 December 2022

9 December 2022

31 August 2022

9 December 2021

  • curprev 05:3405:34, 9 December 2021 Amerikasend talk contribs 1,389 bytes −1,222 Whether the FDA accepts post-hoc analysis, or not, isn't relevant as a cause. Even if it was relevant, it's unclear of when post-hoc analysis' are accepted by the FDA. They accepted post-hoc analysis in the acceptance of the drug Aducanumab. https://www.nature.com/articles/d41586-021-01546-2 The story about Richard Peto is also not relevant as a cause. undo

24 June 2021

13 January 2021

23 January 2020

16 December 2019

22 April 2019

3 January 2019

18 November 2018

10 October 2018

21 September 2018

20 September 2018

11 December 2017

2 December 2017

22 October 2017

20 October 2017

13 October 2017

12 October 2017

11 October 2017

13 December 2016

11 December 2016

5 October 2016

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)